MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Next/Generation Psychedelics

Recent news which mentions Next/Generation Psychedelics

Enveric Biosciences Optimistic On Q4 And Full-Year Results: 'Psychedelic-Inspired' Meds For Future Growth
Tickers ENVB
Tags Psychedelics Benzinga Earnings
From Benzinga
Fed Agency Grants $14M To Gilgamesh For Cardiac-Safe Ibogaine Analog Targeting Opioid Use Disorder
Tickers NEWS
Tags News Cannabis Market News
From Benzinga
Cybin's Novel Psilocybin Topline Data: 79% Remission In Major Depression Symptoms, What's Next?
Tickers CYBN
Tags CYBN Management Psychedelic/Assisted Therapies
From Benzinga
Clearmind Medicine's Reverse Stock Split And Nasdaq Delisting Notice
Tickers CMND
Tags reverse stock split Markets CMND
From Benzinga
Enveric Biosciences' Revenue Drops In Q3 2023 As Next-Gen Psychedelics Advance To Clinical Trials
Tickers ENVB
Tags Cannabis Market News Markets
From Benzinga
Atai Life Sciences' Q3 Earnings: Near $20M Burned QoQ, Says Funding 'Sufficient' To Streamline 2026
Tickers ATAI CMPS
Tags Psychedelics Benzinga CMPS
From Benzinga
Hope For Postpartum Depression: This Company To Launch Clinical Trial On Next-Gen Psychedelic
Tickers MSSTF
Tags MSSTF Guidance News
From Benzinga
Johns Hopkins Will Work With Clearmind On Alcohol Addiction Research Program
Tickers CMND
Tags Psychedelic/Assisted Therapies Management Psychedelics
From Benzinga
Mindset Pharma's $60M Acquisition, Otsuka's Leap Into Next-Gen Psychiatry Solutions
Tickers CYBN DMTTF MSSTF NUGL
Tags Otsuka America Inc/ Next/Generation Psychedelics Markets
From Benzinga
Boosting Next-Gen Mental Health Care: Enveric's New US Patent For Anxiety Treatment
Tickers ENVB
Tags Psychedelics Benzinga Legal
From Benzinga
Psychedelics IP Protection: Cybin Nabs US Patent For Deuterated Analogs, Psilera Advances Next-Gen Library
Tickers CYBN
Tags Psychedelic/Assisted Therapies Legal CYBN
From Benzinga
Enveric's Q2 2023 Financials Show Immediate Need For Budget-Slimming Toward A Clinical-Staged 2024
Tickers ENVB
Tags Earnings Penny Stocks News
From Benzinga
Bright Mind Shares Surge 91% After Reporting Positive EEG Clinical Results Of Next-Gen Compound
Tickers DRUG
Tags clinical trials Penny Stocks News
From Benzinga
Reunion Neuroscience Completes Take-Private Setup: Delisting & Consideration Details
Tickers REUN
Tags Management REUN private development
From Benzinga
Terran Biosciences Steps Into 4-OH-DiPT Prodrug Arena With New Patent Application
Tickers MSSTF REUN
Tags Psychedelics Benzinga REUN
From Benzinga
Reunion Neuroscience On The Brink Of Going Private With Final Court Approval
Tickers FTHWF MSSTF REUN
Tags Psychedelic/Assisted Therapies FTHWF REUN
From Benzinga
Pioneering Psychedelics Scientist Alexander "Sasha" Shulgin's Legacy Lives On Via New Compounds And Research
Tags Alexander Shulgin Next/Generation Psychedelics Markets
From Benzinga
This Biotech Is Entering The Clinical Stage With A Psilocin Analog Targeting Cluster Headaches
Tickers LOBEF
Tags Penny Stocks News Markets
From Benzinga
BetterLife Fast Tracks Its US Patent For Non-Hallucinogenic Compound And Other LSD Derivatives
Tickers BETRF PHRRF
Tags Guidance News Penny Stocks
From Benzinga
Cybin's FY2023 Financials, Guidance And Appointment Of Sanford R. Climan As Strategic Advisor
Tickers CYBN
Tags Next/Generation Psychedelics Cannabis Market News
From Benzinga
UK Greenlights Phase 2 Clinical Trial On Mindset Pharma's Psilocin Drug For Major Depression
Tickers MSSTF
Tags Next/Generation Psychedelics Global Market News
From Benzinga
Canadian Financing: PharmAla Biotech Offers Non-Brokered Private Placement Up To $3.76M
Tickers PMBHF
Tags Financing Management Psychedelic/Assisted Therapies
From Benzinga
Mydecine's Prospectus Supplement Closing Under Share Subscription And Management Update
Tickers MYCOF
Tags Markets Market News Cannabis
From Benzinga
This Company's Psilocybin-Based Non Hallucinogenic Compound Heads Toward Clinical Studies
Tags News Benzinga Psychedelics
From Benzinga
Promising Multiple Sclerosis Drug Candidate Advances: First Clinical Trial Dosing Completed
Tickers HUGE
Tags Psychedelic/Assisted Therapies Benzinga Psychedelics
From Benzinga
Delix's Non-Hallucinogenic Psychoplastogen Enters Phase 1 Trial
Tags Psychoplastogens Markets Market News
From Benzinga
NY Biotech Gets International IP Coverage For Growing Portfolio Of Psychedelic-Derived Novel Drugs
Tags Market News Cannabis Markets
From Benzinga
This Firm Bets On Non-Hallucinogenic Psychedelics, Files Claims For International IP Protection
Tickers MSSTF
Tags MSSTF Guidance News
From Benzinga
Stress, Anxiety, PTSD: 2 NASDAQ-Listed Drug Developers Advance Psychedelic-Inspired Meds
Tickers DRUG SILO
Tags DRUG Management anxiety disorders
From Benzinga
Are Next-Gen Psychedelics The Incoming Solution For Mental Health? Learn It All At Benzinga's Psychedelics Capital Conference
Tags Financing General Psychedelic/Assisted Therapies
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
TOP
Email a Story